| Literature DB >> 29190156 |
Derek C Chang1,2, Jan Klimas1,3, Evan Wood1,4, Nadia Fairbairn1,4.
Abstract
The prevalence of risky opioid use, opioid use disorder, and related harms continue to rise among youth (adolescents and young adults age 15-25) in North America. With an increasing number of opioid overdoses, there remain significant barriers to care for youth with opioid use disorder, and there is an urgent need to expand evidence-based care for treatment of opioid use disorder among this population. Based on the extensive literature on treatment of opioid use disorder among adults, medicated-assisted treatment is likely to be an important or even essential component of treatment of opioid use disorder for most youth. In this article, we outline the current dilemmas and questions regarding the use of medication-assisted treatment among youth with opioid use disorder and propose some potential solutions based on the current evidence.Entities:
Keywords: Youth; adolescent; buprenorphine; methadone; naltrexone; opioid use disorder
Mesh:
Substances:
Year: 2017 PMID: 29190156 PMCID: PMC5815926 DOI: 10.1080/00952990.2017.1399403
Source DB: PubMed Journal: Am J Drug Alcohol Abuse ISSN: 0095-2990 Impact factor: 3.829